About the Women's Health Innovation Portfolio
The Women’s Health Innovation Series is the leading network connecting pharma, biotech, medical device companies, start-ups, investors, payers, researchers, and HCPs to drive innovation at the convergence of healthcare and technology.
Tackling not only the female prevalent verticals (e.g. contraception, pregnancy, breast cancer, maternal health and fertility), but focus on other verticals that disproportionally affect women, or where research for the affect or diagnosis of these diseases has been lacking including; oncology, depression and anxiety, sexual health and wellbeing, heart disease, bone health and more.
Women’s health today is under-served from innovation and clinical science standpoints. This lucrative market is hindered by outdated practices and overlooked by key players. It is imperative to bring the eco-system together to shift mindsets and develop a road map for embracing a holistic, women-centred, accessible approach to healthcare in the US and worldwide.